These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10137568)

  • 1. A conversation with Debra Dullinger, PharmD.
    Dullinger D
    Med Interface; 1994 Oct; 7(10):71-4. PubMed ID: 10137568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving pharmacy benefit market.
    Navarro RP
    Med Interface; 1994 May; 7(5):65-7, 70. PubMed ID: 10134345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving role of pharmacy benefits management firms in a managed care environment.
    O'Leary JS
    Benefits Q; 1995; 11(3):24-33. PubMed ID: 10151118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Get the most out of your PBM (pharmacy benefit manager).
    Mandelker J
    Bus Health; 1994 Nov; 12(11):37-42. PubMed ID: 10138533
    [No Abstract]   [Full Text] [Related]  

  • 5. Exportation of U.S. pharmacy benefit management companies to Canada.
    Navarro RP
    Med Interface; 1995 Jul; 8(7):72-4. PubMed ID: 10143827
    [No Abstract]   [Full Text] [Related]  

  • 6. Working with PBMs (pharmacy benefit managers).
    Peterson C
    Healthplan; 1999; 40(2):83-6, 88-9. PubMed ID: 10537477
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacy benefits management and ambulatory pharmacy services.
    Strandberg LR
    Pharm Pract Manag Q; 1996 Jan; 15(4):19-26. PubMed ID: 10153841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to health care reform by the pharmaceutical industry.
    Krulwich AS
    Food Drug Law J; 1995; 50(1):1-22. PubMed ID: 10342983
    [No Abstract]   [Full Text] [Related]  

  • 9. A whole new world?: pharmaceutical responses to the managed care revolution.
    Balto DA
    Food Drug Law J; 1997; 52(1):83-98. PubMed ID: 10346712
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it risky to ride with a drug company?
    McCarthy R
    Bus Health; 1996 Jan; 14(1):30-4, 36. PubMed ID: 10156381
    [No Abstract]   [Full Text] [Related]  

  • 11. The changing environment in health care.
    Beers DO
    Food Drug Law J; 1995; 50(2):293-4. PubMed ID: 10342996
    [No Abstract]   [Full Text] [Related]  

  • 12. An industry in evolution.
    Blissenbach HF
    Med Interface; 1995 Oct; 8(10):80-1, 88. PubMed ID: 10152328
    [No Abstract]   [Full Text] [Related]  

  • 13. How well does your PBM perform?
    McCarthy R
    Bus Health; 1999 Jan; 17(1):24-9. PubMed ID: 10345211
    [No Abstract]   [Full Text] [Related]  

  • 14. Public payers foot greater pharmacy costs.
    Manag Care; 2006 Jul; 15(7):70. PubMed ID: 16898070
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing chronic disease.
    Mandelker J
    Bus Health; 1994 Nov; 12(11):45, 49-50. PubMed ID: 10138535
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacy benefit management companies: redefining their role in health care risk management.
    Lloyd J
    Health Care Innov; 1995; 5(5):29-32. PubMed ID: 10160497
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
    Navarro RP
    Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation issues in disease management programs: a pharmaceutical company perspective.
    Browne RA
    Med Interface; 1995 Apr; 8(4):60-5, 69. PubMed ID: 10141767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A look ahead for managed care pharmacy in 2006.
    Giaquinta D
    Manag Care Interface; 2006 Feb; 19(2):39-40. PubMed ID: 16529079
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacy benefit management: the right Rx?
    Etheredge L
    Res Agenda Brief; 1995 Apr; (1):1-11. PubMed ID: 12856664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.